Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
METHYR: Metformin Effect on Fertility in Women Treated With 131I for Thyroid Cancer
NCT05468554Phase 3Recruiting
- Sponsor
- Medical University of Białystok
- Start
- Nov 2022
- Primary completion
- Jan 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of liquid metformin (Aspargo Labs) in thyroid cancer (3 arms), sponsored by Medical University of Białystok. Primary endpoint: Changes in AMH, Inhibin B and FSH levels at 4 years. Started Nov 2022; status: recruiting.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
thyroid cancer
Beyond the preview
Go deeper on NCT05468554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05468554.